ITALFARMACO was founded in Italy in 1938 and is now present in over 90 countries. We develop and provide medicines in several therapeutic areas, including those for rare diagnoses and diseases that require specialist care.
ITALFARMACO Nordics is a part of the global company ITALFARMACO Group.
Our vision, to deliver modern therapies within the field of neuromuscular diseases, is inspired by the group's extensive experience in research, development, and manufacturing of medicines. We combine this with a knowledgeable team with many years of Nordic experience in working with rare diseases, with our initial goal being to contribute to more treatment options for those living with Duchenne muscular dystrophy.
We listen to and learn from those who know the most about life with a rare disease, the patients and their families. Through innovative research, development, and years of collaboration with policymakers, healthcare providers, and patients, we strive to improve the lives of those who suffer from rare diseases.
Quality and safety are our top priorities. Our medicines are manufactured in state-of-the-art production facilities in Europe. We track each of our drugs meticulously from creation to the finished product to ensure its pharmaceutical and therapeutic quality.
We care about people's well-being. Behind our modern and innovative products are dedicated employees who wholeheartedly work to offer medical solutions that benefit the entire healthcare chain.
ITALFARMACO Group’s first in-house developed product reached the market in 1984. Since then, we have delivered several successful products in a range of disease areas. Our current pipeline is focused on developments within the fields of inflammation, oncology and neuromuscular degeneration. Our vision is, not only to develop new medicines, but also to improve existing therapies to increase the safety and efficacy for patients.
Vårt samarbete with academia, clinicians and patients is a prerequisite for us. This attitude coupled with consistent and dedicated work, allows us to deliver innovative world-class medicines. As a result, the commitment of our employees is critical and one of our greatest assets.
In a transparent, flexible, and inclusive world, we believe that all individuals should be given space to achieve their ambitions. Therefore, we cherish an open and secure culture. By working to support each other and contribute in the best way possible, we create innovative and flexible solutions tailored for healthcare professionals and patients.
We value equality, equal rights, and sustainable balance. In our workplaces, we prioritize both a healthy work-life balance, both between work and leisure, as well as quality and sustainability.
We also strive for all patients to have as equal access to treatments as possible.
Kristina Grafström
Rare Disease Lead, Nordics
DK-ITFRD-24-00005 September 2024
Italfarmaco Nordics
The Park Forskaren
Hagaplan 4
113 68, Stockholm, SWEDEN
Copyright © Italfarmaco Nordics. All rights reserved.
EN 
SE